Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

A Matching-Adjusted Indirect Comparison (MAIC) Case Study: Zanubrutinib vs. Acalabrutinib

Watch the video with Dr. Brian Koffman explaining the comparison of zanubrutinib to acalabrutinib using a scientific method called matching-adjusted indirect comparison (MAIC).

This program is sponsored by BeiGene